Immortalization of primary murine B lymphocytes with oncogene-containing retroviral vectors. 1990

R W Overell, and K E Weisser, and B Hess, and R Goodwin, and L Clark, and K H Grabstein
Immunex Corporation, Seattle, WA 98101.

UI MeSH Term Description Entries
D009857 Oncogenes Genes whose gain-of-function alterations lead to NEOPLASTIC CELL TRANSFORMATION. They include, for example, genes for activators or stimulators of CELL PROLIFERATION such as growth factors, growth factor receptors, protein kinases, signal transducers, nuclear phosphoproteins, and transcription factors. A prefix of "v-" before oncogene symbols indicates oncogenes captured and transmitted by RETROVIRUSES; the prefix "c-" before the gene symbol of an oncogene indicates it is the cellular homolog (PROTO-ONCOGENES) of a v-oncogene. Transforming Genes,Oncogene,Transforming Gene,Gene, Transforming,Genes, Transforming
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002472 Cell Transformation, Viral An inheritable change in cells manifested by changes in cell division and growth and alterations in cell surface properties. It is induced by infection with a transforming virus. Transformation, Viral Cell,Viral Cell Transformation,Cell Transformations, Viral,Transformations, Viral Cell,Viral Cell Transformations
D005822 Genetic Vectors DNA molecules capable of autonomous replication within a host cell and into which other DNA sequences can be inserted and thus amplified. Many are derived from PLASMIDS; BACTERIOPHAGES; or VIRUSES. They are used for transporting foreign genes into recipient cells. Genetic vectors possess a functional replicator site and contain GENETIC MARKERS to facilitate their selective recognition. Cloning Vectors,Shuttle Vectors,Vectors, Genetic,Cloning Vector,Genetic Vector,Shuttle Vector,Vector, Cloning,Vector, Genetic,Vector, Shuttle,Vectors, Cloning,Vectors, Shuttle
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001402 B-Lymphocytes Lymphoid cells concerned with humoral immunity. They are short-lived cells resembling bursa-derived lymphocytes of birds in their production of immunoglobulin upon appropriate stimulation. B-Cells, Lymphocyte,B-Lymphocyte,Bursa-Dependent Lymphocytes,B Cells, Lymphocyte,B Lymphocyte,B Lymphocytes,B-Cell, Lymphocyte,Bursa Dependent Lymphocytes,Bursa-Dependent Lymphocyte,Lymphocyte B-Cell,Lymphocyte B-Cells,Lymphocyte, Bursa-Dependent,Lymphocytes, Bursa-Dependent
D012190 Retroviridae Family of RNA viruses that infects birds and mammals and encodes the enzyme reverse transcriptase. The family contains seven genera: DELTARETROVIRUS; LENTIVIRUS; RETROVIRUSES TYPE B, MAMMALIAN; ALPHARETROVIRUS; GAMMARETROVIRUS; RETROVIRUSES TYPE D; and SPUMAVIRUS. A key feature of retrovirus biology is the synthesis of a DNA copy of the genome which is integrated into cellular DNA. After integration it is sometimes not expressed but maintained in a latent state (PROVIRUSES). Leukemogenic Viruses,Leukoviruses,Oncornaviruses,Oncovirinae,Oncoviruses,Oncoviruses, Type C,RNA Tumor Viruses,Retroviruses,Type C Oncoviruses,C Oncovirus, Type,C Oncoviruses, Type,Leukemogenic Virus,Leukovirus,Oncornavirus,Oncovirus,Oncovirus, Type C,RNA Tumor Virus,Retrovirus,Tumor Virus, RNA,Tumor Viruses, RNA,Type C Oncovirus,Virus, Leukemogenic,Virus, RNA Tumor,Viruses, Leukemogenic,Viruses, RNA Tumor
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus

Related Publications

R W Overell, and K E Weisser, and B Hess, and R Goodwin, and L Clark, and K H Grabstein
November 2009, Molecular therapy : the journal of the American Society of Gene Therapy,
R W Overell, and K E Weisser, and B Hess, and R Goodwin, and L Clark, and K H Grabstein
January 2009, Methods in molecular biology (Clifton, N.J.),
R W Overell, and K E Weisser, and B Hess, and R Goodwin, and L Clark, and K H Grabstein
June 1995, Proceedings of the National Academy of Sciences of the United States of America,
R W Overell, and K E Weisser, and B Hess, and R Goodwin, and L Clark, and K H Grabstein
January 2018, Methods in molecular biology (Clifton, N.J.),
R W Overell, and K E Weisser, and B Hess, and R Goodwin, and L Clark, and K H Grabstein
June 1998, Critical reviews in oncology/hematology,
R W Overell, and K E Weisser, and B Hess, and R Goodwin, and L Clark, and K H Grabstein
January 1984, Nature,
R W Overell, and K E Weisser, and B Hess, and R Goodwin, and L Clark, and K H Grabstein
March 2001, Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi,
R W Overell, and K E Weisser, and B Hess, and R Goodwin, and L Clark, and K H Grabstein
September 1989, Journal of virology,
R W Overell, and K E Weisser, and B Hess, and R Goodwin, and L Clark, and K H Grabstein
May 1985, Science (New York, N.Y.),
R W Overell, and K E Weisser, and B Hess, and R Goodwin, and L Clark, and K H Grabstein
January 2011, Molecular medicine (Cambridge, Mass.),
Copied contents to your clipboard!